NewcelX (NCEL)
NASDAQ:NCEL
NCEL Stock Chart & Stats
$2.66
--
Market closed
$2.66
--
Day’s Range― - ―
52-Week Range$1.83 - $30.79
Previous CloseN/A
VolumeN/A
Average Volume (3M)320.89K
Market Cap
$18.65M
Enterprise Value-$1.65M
Total Cash (Recent Filing)$3.07M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.91
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,345,184
10 Day Avg. Volume34,320
30 Day Avg. Volume320,894
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.13
Price to Sales (P/S)0.00
P/FCF Ratio-0.37
Enterprise Value/Market Cap-0.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-4.17K
Enterprise Value/Ebitda0.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NewcelX News
NCEL FAQ
What was NewcelX’s price range in the past 12 months?
NewcelX lowest stock price was $1.83 and its highest was $30.79 in the past 12 months.
What is NewcelX’s market cap?
NewcelX’s market cap is $18.65M.
When is NewcelX’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NewcelX’s earnings last quarter?
Currently, no data Available
Is NewcelX overvalued?
According to Wall Street analysts NewcelX’s price is currently Overvalued.
Does NewcelX pay dividends?
NewcelX does not currently pay dividends.
What is NewcelX’s EPS estimate?
NewcelX’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NewcelX have?
NewcelX has 5,345,184 shares outstanding.
What happened to NewcelX’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NewcelX?
Currently, no hedge funds are holding shares in NCEL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NewcelX
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Ownership Overview
Options Prices
Currently, No data available
---